HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug.
about
Binding mode characterization of NBD series CD4-mimetic HIV-1 entry inhibitors by X-ray structure and resistance study.A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry.Peptide Triazole Inactivators of HIV-1 Utilize a Conserved Two-Cavity Binding Site at the Junction of the Inner and Outer Domains of Env gp120.A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruptionCD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge.Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.Activity of the HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068, against CD4-independent viruses and HIV-1 envelopes resistant to other entry inhibitors.Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent endocytosisCrystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529.Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.Detailed study of the interaction between human herpesvirus 6B glycoprotein complex and its cellular receptor, human CD134.Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068.High throughput generation and characterization of replication-competent clade C transmitter-founder simian human immunodeficiency viruses.
P2860
Q34057606-428C206A-5513-4BE6-AB32-32DEAB5E4A57Q34509949-5A31DA0D-02F3-4C02-9597-3D5BB4350C08Q35835515-13DAD835-8B57-479B-B685-0FEB21F16209Q37238636-3E27C827-E449-4597-B693-758CC2CB3F63Q37323948-42C9A689-BBBF-43EC-B67E-8CBE8DC1FCA4Q38816992-3BE8D77C-9C78-4D2D-AF35-37A872E7EA76Q39178072-01DA66DC-0563-47FB-A91C-D81AFA499D06Q39470792-1611266E-31F2-4A81-ABD0-21528C726600Q40076760-A6D2C86D-50EF-4349-8F61-D8FF9816996DQ40366464-2338C9F3-CA14-4EB1-B7F4-B3AD5273A27DQ42207185-03FE6C16-3172-4DD8-B22F-3FA591D03A8CQ42262298-C402A0BE-0D43-4724-9EB4-0DADCD8668BBQ53682331-1069E167-98F6-4A1C-9559-B306A946653B
P2860
HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
HIV gp120 H375 is unique to HI ...... a candidate microbicide drug.
@en
HIV gp120 H375 is unique to HI ...... a candidate microbicide drug.
@nl
type
label
HIV gp120 H375 is unique to HI ...... a candidate microbicide drug.
@en
HIV gp120 H375 is unique to HI ...... a candidate microbicide drug.
@nl
prefLabel
HIV gp120 H375 is unique to HI ...... a candidate microbicide drug.
@en
HIV gp120 H375 is unique to HI ...... a candidate microbicide drug.
@nl
P2093
P2860
P356
P1476
HIV gp120 H375 is unique to HI ...... , a candidate microbicide drug
@en
P2093
Daniela Moisi
Mark A Wainberg
Maureen Oliveira
Peter K Quashie
Ruxandra-Ilinca Ibanescu
Susan M Schader
Susan P Colby-Germinario
P2860
P304
P356
10.1128/AAC.00639-12
P407
P577
2012-05-21T00:00:00Z